Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antibodies against fibroblast growth factor 23

A fibroblast, growth factor technology, applied in the direction of fibroblast growth factor, anti-growth factor immunoglobulin, growth factor/inducing factor, etc.

Inactive Publication Date: 2005-07-13
KYOWA HAKKO KIRIN CO LTD
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, no substance that selectively inhibits or removes FGF-23 using the above method has been found.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibodies against fibroblast growth factor 23
  • Antibodies against fibroblast growth factor 23
  • Antibodies against fibroblast growth factor 23

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0082] Figure 1B shows the full-length FGF-23 protein, N-terminal fragment and C-terminal fragment purified from the supernatant of CHO-FGF-23 cell culture, cell culture supernatant of CHO-FGF-23 The measurement results obtained after separation by SDS-polyacrylamide gel electrophoresis and stained with Coomassie brilliant blue (CBB).

[0083] Figure 1C shows the assay results of a recombinant FGF-23 protein, a recombinant FGF-23RQ protein, and its metabolites by Western blotting using an anti-FGF 23-148 antibody, this anti-FGF 23- 148 antibody was obtained by separating the culture supernatants of CHO-FGF-23H cells and CHO-FGF-23RQ cells, and then separating the cells by SDS-polyacrylamide gel electrophoresis. (Example 5)

Embodiment 5

[0084] Figure 2 shows the detection of FGF-23H protein by sandwich ELISA using a hFGF23-25 ​​antibody as an immobilized antibody and a hFGF23-237 as a detection antibody (this detection antibody is a polyclonal antibody against FGF-23). The result obtained after performing the measurement.

Embodiment 7

[0086] Figure 3 shows the results of immunoprecipitation of FGF-23H protein with anti-FGF-23 monoclonal antibody, separation of the protein by SDS-polyacrylamide gel electrophoresis, and detection of the protein with 2A2B antibody and 1C3H antibody. (Example 10)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The purpose of the present invention is to provide an antibody against fibroblast growth factor 23. The antibody is obtained by immunizing an animal with a polypeptide which comprises an amino acid sequence represented by SEQ ID NO: 1, or an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 1 by deletion, substitution, or addition of 1 or several amino acids, and has fibroblast growth factor-23 activity and activity to control phosphate metabolism or vitamin D metabolism, and is shown by the following (a), (b), or (c): (a) an antibody, which recognizes an amino acid sequence between the 180 and the 194, or the 237 and the 251<st> amino acid residues represented by SEQ ID NO: 1; (b) an antibody, which is produced by a hybridoma whose accession number is FERM BP-7838, FERM BP-7839, FERM BP-7840, or FERM BP-8268; or (c) an antibody, which is competitive with the antibody produced by the hybridoma whose accession number is FERM BP-7838, FERM BP-7839, FERM BP-7840, or FERM BP-8268 upon binding with the polypeptide comprising the amino acid sequence represented by SEQ ID NO: 1. <IMAGE>

Description

technical field [0001] The present invention relates to antibodies against fibroblast growth factor-23 (FGF-23). [0002] More specifically, the present invention relates to antibodies that provide methods for diagnosing diseases or pathological conditions associated with accumulation or reduction of FGF-23 protein in vivo by appropriately detecting and measuring FGF-23, said method being capable of suppressing FGF -23 to improve or treat the symptoms or pathological state of the disease caused by the excessive effect of FGF-23, the present invention also relates to a method for preparing an antibody and a method for using the antibody. Background technique [0003] Fibroblast growth factor was purified for the first time from calf pituitary as a stimulating substance of the fibroblast cell line NIH3T3. Then, similar proteins were identified in various tissues, and a group of these substances formed a polypeptide family (FGF family). To date, 22 types of proteins belonging...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/00A61P19/08C07K14/50C07K16/22C12P21/08
CPCA61K39/00A61K2039/505C07K14/50C07K16/22A61P13/00A61P13/12A61P17/04A61P19/00A61P19/08A61P19/10A61P21/00A61P3/00A61P3/12A61P3/14A61P35/00A61P5/06A61P5/18A61P5/20A61P7/08C07K16/18A61K39/395G01N33/53
Inventor 山崎雄司岛田考志山下武美
Owner KYOWA HAKKO KIRIN CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products